Home » Topics » Regulatory

Regulatory
RSS

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

NDA for subcutaneous Repronex approved by FDA

Aug. 31, 1999

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Aug. 27, 1999

InterMune files BLA for Actimmune for treatment of osteopetrosis

Aug. 25, 1999

Bio-Technology General granted additional patent allowance for oxandrolone

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

Chiron initiates phase III study of Proleukin for HIV

Aug. 23, 1999

FDA approves Organon's short-acting neuromuscular blocker Raplon

Aug. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...